← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 2012Last known activity
Oct 31, 2025
Timeline
2010s
- May 1, 2012
ECOG-ACRIN Cancer Research Group— Founded
Drugs by trial phase (158 distinct, 180 trials)
Phase 3 (90 own, 0 via acquisition)
Phase 2 (68 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma, Bronchiolo-Alveolar
- Adenocarcinoma, Mucinous
- Adenocarcinoma of Lung
- Adenoma, Islet Cell
- Anemia
- Anus Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma in Situ
- Carcinoma, Islet Cell
- Carcinoma, Merkel Cell
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Signet Ring Cell
- Carcinoma, Small Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Carcinoma, Verrucous
- Cholangiocarcinoma
- Colonic Neoplasms
- Colorectal Neoplasms
- Colorectal Neoplasms, Hereditary Nonpolyposis
- Cystadenocarcinoma
- Endometrial Neoplasms
- Esophageal Neoplasms
- Esophageal Squamous Cell Carcinoma
- Fatigue
- Gallbladder Neoplasms
- Gastrinoma
- Gastrointestinal Neoplasms
- Glioma
- Glucagonoma
- Hodgkin Disease
- Hypersensitivity
- Insulinoma
- Kidney Neoplasms
- Laryngeal Neoplasms
- Leukemia
- Leukemia, Erythroblastic, Acute
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Megakaryoblastic, Acute
- Leukemia, Monocytic, Acute
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid, Chronic-Phase
- Leukemia, Myelomonocytic, Acute
- Leukemia, Myelomonocytic, Chronic
- Leukemia, Myelomonocytic, Juvenile
- Leukemia, Promyelocytic, Acute
- Lip Neoplasms
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Melanoma
- Mouth Neoplasms
- Multiple Myeloma
- Myelodysplastic Syndromes
- Neoplasm Metastasis
- Neoplasm, Residual
- Neoplasms
- Neoplasms, Plasma Cell
- Neoplasms, Second Primary
- Neuroendocrine Tumors
- Neurotoxicity Syndromes
- Oropharyngeal Neoplasms
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Papilloma
- Papillomavirus Infections
- Peripheral Nervous System Diseases
- Philadelphia Chromosome
- Pneumonia
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Prostatic Neoplasms
- Rectal Neoplasms
- Recurrence
- Salivary Gland Neoplasms
- Skin Neoplasms
- Small Cell Lung Carcinoma
- Smoldering Multiple Myeloma
- Somatostatinoma
- Squamous Cell Carcinoma of Head and Neck
- Stomach Neoplasms
- Syndrome
- Thyroid Diseases
- Thyroid Neoplasms
- Ureteral Neoplasms
- Urinary Bladder Neoplasms
- Uterine Neoplasms
Recent trials (50)
- NCT06948084OfficialPhase 2Oct 31, 2025
- NCT07001748OfficialPhase 2/Phase 3Aug 19, 2025
- NCT07001748Lead sponsorPhase 2/Phase 3Aug 19, 2025
- NCT07085728OfficialPhase 2Aug 11, 2025
- NCT06732401OfficialPhase 3Mar 14, 2025
- NCT06524544OfficialPhase 3Feb 6, 2025
- NCT06649812OfficialPhase 2Jan 17, 2025
- NCT06592924CollaboratorPhase 3Jan 15, 2025
- NCT06724237OfficialPhase 3Dec 1, 2024
- NCT06317649OfficialPhase 2Sep 27, 2024
- NCT06475989OfficialPhase 3Sep 13, 2024
- NCT06475989Lead sponsorPhase 3Sep 13, 2024
- NCT06422806OfficialPhase 3Sep 11, 2024
- NCT06205485CollaboratorPhase 3Jun 26, 2024
- NCT05836584Overall official - principal investigatorPhase 2Jun 8, 2024
Details
- Founded
- Philadelphia, PA, US May 1, 2012
- Last known activity
- Oct 31, 2025